v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Apr. 04, 2025
Mar. 29, 2024
Cash flows from operating activities:    
Net income (loss) $ (55,705) $ (71,841)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 71,435 73,404
Stock-based compensation expense 7,407 6,431
Non-cash interest expense 1,348 1,245
Fair value loss on contingent acquisition shares 1,787 13,443
Loss on currency hedges 0 11,123
Deferred income tax benefit (1,769) (9,966)
(Gain) loss on sale of property, plant and equipment (527) 265
Changes in operating assets and liabilities:    
Trade receivables, net (15,977) (12,009)
Inventories, net (23,295) (11,051)
Accounts payable 4,189 (11,752)
Other operating assets and liabilities 9,511 (25,448)
Net cash used in operating activities (1,596) (36,156)
Cash flows from investing activities:    
Purchases of property, plant and equipment and intangibles (43,262) (36,928)
Payments for acquisitions, net of cash received, and investments (18,858) (760,914)
Cash received upon settlement of derivatives 1,601 0
Net cash used in investing activities (60,519) (797,842)
Cash flows from financing activities:    
Proceeds from borrowings on term credit facility 0 400,000
Repayments of borrowings under term credit facility (5,000) (5,000)
Proceeds from borrowings on revolving credit facilities and other 72,000 480,000
Repayments of borrowings on revolving credit facilities and other (10,438) (1,956)
Payment of debt issuance costs 0 (703)
Payments of tax withholding for stock-based awards (3,447) (4,772)
Proceeds from issuance of common stock, net 341 871
Deferred consideration payments and other (2,265) (3,900)
Net cash provided by financing activities 51,191 864,540
Effect of foreign exchange rates on Cash and cash equivalents 1,217 (828)
Increase (decrease) in Cash and cash equivalents (9,707) 29,714
Cash and cash equivalents, beginning of period 48,167 44,832
Cash and cash equivalents, end of period 38,460 74,546
Supplemental disclosures - Non-cash investing activities:    
Fair value of contingently issuable shares in business acquisition $ 0 $ 107,877